- Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences
Mar 28, 2024, 4:01 PM EDT - Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals
Mar 27, 2024, 7:30 AM EDT - Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results
Feb 8, 2024, 4:15 PM EST - Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use
Jan 23, 2024, 7:30 AM EST - NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
Jan 9, 2024, 9:15 AM EST - Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results
Nov 13, 2023, 4:30 PM EST - Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference
Nov 3, 2023, 7:30 AM EDT - Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock
Oct 26, 2023, 9:10 AM EDT - National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
Aug 15, 2023, 7:30 AM EDT - Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results
Aug 10, 2023, 4:15 PM EDT